Recall of Device Recall Haemonetics cardioPAT

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Haemonetics Corporation.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    57805
  • Event Risk Class
    Class 2
  • Event Number
    Z-1391-2011
  • Event Initiated Date
    2011-01-25
  • Event Date Posted
    2011-02-22
  • Event Status
    Terminated
  • Event Country
  • Event Terminated Date
    2013-01-14
  • Event Source
    USFDA
  • Event Source URL
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    autotransfusion System - Product Code CAC
  • Reason
    Update instructions for use for the cardiopat® manual for leak detection. user may mis-interpret the air-leak rate displayed by the cardiopat device when making a determination about chest-drain removal, which could result in the patient experiencing a pneumothorax.
  • Action
    Haemonetics issued a Field Correction Notice on 1/25/11 . with the Air Leak Detection addendum and index be inserted into the appropriate document, applied to all cardioPAT@ devices on site. The serial number for each cardioPAT device on site should be recorded on the attached acknowledgement and the completed acknowledgement should be returned to your Haemonetics Sales Consultant. A Haemonetics Sales Consultant will train on the content of these items and insert them into the Operator Manuals

Device

  • Model / Serial
    All serial numbers
  • Product Classification
  • Device Class
    2
  • Implanted device?
    No
  • Distribution
    Worldwide distribution, including USA, Australia, Belgium, Canada, Switzerland, China, Germany, Finland, France, United Kingdom, Hong Kong, Israel, Italy, Japan, Netherlands, Russian Federation, and Sweden.
  • Product Description
    Haemonetics cardioPAT Cardiovascular - autotransfusion System || Catalog Number: 02050-US
  • Manufacturer

Manufacturer

  • Manufacturer Address
    Haemonetics Corporation, 400 Wood Road, Braintree MA 02184-2412
  • Manufacturer Parent Company (2017)
  • Source
    USFDA